Skip to main content

Find Clinical Trials

Home
Conditions
TDP-43 Proteinopathies

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

870 public trials 211 recruiting studies

Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Enrolling by Invitation

Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM Device

NCT07222605

Conditions: Alzheimer Disease, Basal Ganglia Diseases, Brain Diseases, +23 more
Locations: CareONE Concierge Atlanta, Georgia, United States

View Trial Details

Enrolling by Invitation

Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders

NCT04680130

Conditions: Aphasia, Apraxia of Speech, Apraxias, +44 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Enrolling by Invitation

Primary Progressive Aphasia Multicomponent Language Treatment Study

NCT06649084

Conditions: Aphasia, Aphasia, Primary Progressive, Aphasia, Progressive, +27 more
Locations: University of Texas Austin, Texas, United States

View Trial Details

Enrolling by Invitation

Speech-Language Treatment With Remotely Supervised Transcranial Direct Current Stimulation in Primary Progressive Aphasia

NCT05901233

Conditions: Alzheimer Disease, Aphasia, Aphasia, Primary Progressive, +22 more
Locations: Memory and Aging Center, University of California, San Francisco San Francisco, California, United States

University of Texas Austin, Texas, United States

View Trial Details

Enrolling by Invitation

Electrophysiology and Ultrasound of Respiratory Muscles and Respective Nerves to Predict Respiratory Insufficiency in ALS

NCT06841341

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +11 more
Locations: Jagiellonian University Medical College, Department of Neurology Krakow, Lesser Poland Voivodeship, Poland

View Trial Details

Enrolling by Invitation

Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders

NCT06605612

Conditions: Amyotrophic Lateral Sclerosis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +67 more
Locations: Friedrich-Baur-Institut, Neurologische Klinik und Poliklinik, LMU Klinikum, Ludwig-Maximilians-Universität München München, Bavaria, Germany

View Trial Details

Enrolling by Invitation

Control of Assistive Devices Via Brain-Computer Interface Technology

NCT06710626

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +20 more
Locations: Barrow Neurological Institute Phoenix, Arizona, United States

View Trial Details

Enrolling by Invitation

An Innovative Method in SAliva Samples for the Early Differential Diagnosis of High-impact NeuroDegenerative Diseases Through Raman Spectroscopy

NCT06875739

Conditions: Alzheimer Disease, Amyotrophic Lateral Sclerosis, Basal Ganglia Diseases, +21 more
Locations: Azienda Ospedaliera Universitaria di Cagliari Cagliari, Italy

IRCCS Fondazione Don Carlo Gnocchi Florence, Italy

Laboratorio Congiunto di Ricerca DON GNOCCHI - UNIFI neurogenetica in riabilitazione - NGR Florence, Italy

IRCCS Fondazione Don Carlo Gnocchi, Milano Milan, Italy

View Trial Details

Enrolling by Invitation

The Role of Advanced Electroencephalographic Data as Marker of Pathology and Prognosis in Primary Dementias

NCT06826157

Conditions: Alzheimer Disease, Basal Ganglia Diseases, Brain Diseases, +24 more
Locations: IRCCSS San Raffaele Milan, Italy

View Trial Details

Enrolling by Invitation

Safety, Tolerability, and Pharmacokinetics of FHND1002 Granules in Healthy Adults

NCT06782958

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations: The first hospital of Lanzhou University Lanzhou, Gansu, China

View Trial Details